Abstract
  • Population : Immunocompetent individuals living in JE-endemic areas
  • Intervention: Two doses (primary series) of inactivated Vero cell-derived vaccine administered ≥12 months previously
  • Comparison: Placebo/no vaccination/other JE vaccine
  • Outcome : JE disease (immunogenicity accepted)
  • GRADE table
  • Japanese encephalitis